Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Tesch

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Geburtshilfe Und Frauenheilkunde|March 7, 2020
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known TherapiesAndreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialSibylle Loibl, Michael Untch, Jens Huober, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion DiagnosticsDiana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, et al.
Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.
NPJ Breast Cancer|April 7, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapyJens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast CancerFlorian Schütz, Peter A Fasching, Manfred Welslau, et al.
Journal of Cancer Research and Clinical Oncology|June 19, 2025
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA studyAndreas Schneeweiss, Peter A Fasching, Marc Thill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro studyMichael Untch, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro studyGunter von Minckwitz, Mahdi Rezai, Sibylle Loibl, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Geburtshilfe Und Frauenheilkunde|March 7, 2020
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known TherapiesAndreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialSibylle Loibl, Michael Untch, Jens Huober, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion DiagnosticsDiana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, et al.
Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.
NPJ Breast Cancer|April 7, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapyJens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast CancerFlorian Schütz, Peter A Fasching, Manfred Welslau, et al.
Journal of Cancer Research and Clinical Oncology|June 19, 2025
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA studyAndreas Schneeweiss, Peter A Fasching, Marc Thill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro studyMichael Untch, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro studyGunter von Minckwitz, Mahdi Rezai, Sibylle Loibl, et al.
Pageof 18